Tuberous Sclerosis Complex and Epilepsy: Recent Developments and Future Challenges

Epilepsia - Tập 48 Số 4 - Trang 617-630 - 2007
Gregory L. Holmes1, Carl E. Stafstrom
1Neuroscience Center at Dartmouth, Section of Neurology, Dartmouth Medical School, Hanover, New Hampshire, USA. [email protected]

Tóm tắt

Summary: Tuberous sclerosis complex (TSC) is a congenital syndrome characterized by the widespread development of benign tumors in multiple organs, caused by mutations in one of the tumor suppressor genes, TSC1 or TSC2. About 80% of affected patients have a new mutation, and the remaining 20% have inherited a TSC gene mutation from a parent. The disorder affects approximately 1 in 6000 individuals. Cortical tubers are the neuropathological hallmark of TSC. The most common neurological manifestations of TSC are epilepsy, mental retardation, and autistic behavior. Epilepsy occurs in up to 80–90% of patients and is often intractable, with a poor response to anticonvulsant medications.While the molecular basis of TSC is well established, far less is known about the mechanisms of epilepsy in this disorder. In this article, we first summarize known clinical aspects of TSC with emphasis on its neurological features. Then, based on the molecular, pathological, immunohistochemical, neurochemical, and physiological properties of tubers in patients with TSC and in animal models, we discuss possible mechanisms of seizures and epileptogenesis in TSC. Finally, we provide an updated literature review and a consensus statement from the Tuberous Sclerosis Complex Working Group for future research into the mechanisms of epilepsy in TSC.

Từ khóa


Tài liệu tham khảo

10.1007/s004010051074

10.1212/WNL.54.10.1976

10.1177/088307380401900401

10.1038/sj.onc.1209090

10.1177/08830738040190091101

10.1212/01.wnl.0000183747.05269.2d

10.1111/j.1528-1157.1993.tb00442.x

10.1002/mrdd.20024

10.1016/S0140-6736(97)80012-8

10.1093/brain/awf124

Bourneville DM, 1880, Sclérose tubereuse des circonvolutions cérébrales: idiotie et épilepsie hémiplégique, Archives of Neurology (Paris), 1, 81

Bourneville DM, 1881, Encéphalite ou sclérosis tubéreuse des circonvolutions cérébrales, Archives of Neurology (Paris), 1, 390

10.1093/jnen/63.12.1236

10.1007/s004390000348

10.1002/ana.410440603

10.1111/j.1528-1167.2005.00353.x

10.1111/j.1469-8749.1987.tb02520.x

10.1177/08830738050200040901

10.1111/j.1528-1157.1990.tb05516.x

10.1086/316951

10.1111/j.1469-8749.2006.tb01302.x

10.1177/08830738050200101301

Eker R, 1981, Hereditary renal adenomas and adenocarcinomas in rats, Diagnostic Histopathology, 4, 99

10.1016/S0140-6736(03)13044-9

10.1002/glia.10324

10.1097/00004583-199711000-00019

10.1002/ana.20784

10.1007/s00726-006-0359-1

10.1038/sj.onc.1209660

10.1101/gad.901101

10.1038/ncb847

10.1016/S1097-2765(03)00220-X

Gillberg C, 1992, Subgroups in autism: are there behavioural phenotypes typical of underlying medical conditions?, Journal of Intellectual Disability Research, 36, 201, 10.1111/j.1365-2788.1992.tb00508.x

10.1212/01.wnl.0000168908.78118.99

Gomez MR, 1999, Tuberous Sclerosis Complex, 10, 10.1093/oso/9780195122107.003.0002

Gomez MR, 1999, Tuberous Sclerosis Complex, 3, 10.1093/oso/9780195122107.003.0001

Gomez MR, 1999, Tuberous Sclerosis Complex: Developmental Perspectives in Psychiatry, 29, 10.1093/oso/9780195122107.003.0004

10.1212/WNL.51.5.1263

10.1111/j.0013-9580.2004.04010.x

Hancock E, 2003, Treatment of infantile spasms, Cochrane Database of Systematic Reviews, CD001770

Henske EP, 1997, Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two‐hit model for the pathogenesis of tuberous sclerosis tumors, The American Journal of Pathology, 151, 1639

10.1101/gad.1110003

10.1038/ncb839

10.1038/ng1494

10.1128/MMBR.69.1.79-100.2005

10.1111/j.1469-8749.1991.tb14947.x

10.1111/j.1528-1167.2005.00289.x

10.1002/ana.21037

10.1111/j.1528-1167.2006.00373.x

10.1212/01.WNL.0000106947.18643.1D

10.1111/j.1750-3639.1999.tb00209.x

10.1086/302381

10.1002/ijc.21542

10.1007/s10571-005-4932-z

10.1177/088307380001501003

10.1177/08830738040190020401

10.1177/08830738050200121101

10.1177/08830738050200050701

10.1203/01.PDR.0000147727.78571.07

Kobayashi T, 1999, Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ‐line Tsc2 mutation in mice, Cancer Research, 59, 1206

10.1111/j.1528-1157.2000.tb00327.x

10.1111/j.1528-1167.2005.00266.x

10.1046/j.1469-1809.2003.00012.x

10.1093/hmg/ddi260

10.1212/01.WNL.0000160389.93984.53

10.1016/S0887-8994(03)00407-7

10.1002/ana.10579

10.1074/jbc.C500169200

10.1016/S0140-6736(04)17400-X

10.1016/S1474-4422(05)70199-X

10.1097/00019052-200104000-00005

10.1212/01.WNL.0000127773.72699.C8

10.1016/S0969-9961(03)00127-X

10.1038/ncb0902-e214

Meikle LM, 2005, Characterization of a murine neuronal specific knockout of TSC1, Epilepsia, 46, 273

10.1007/s004010051152

10.1093/jnen/59.3.188

10.1016/S0387-7604(01)00304-7

10.1007/s00401-003-0778-y

10.1016/S1071-9091(98)80005-3

10.1002/(SICI)1098-1004(199911)14:5<412::AID-HUMU7>3.0.CO;2-K

10.1136/adc.2003.026815

10.1172/JCI7319

Osborne J, 1993, Seizures and intellectual disability associated with tuberous sclerosis, Developmental Medicine and Child Neurology, 35, 276

Ouyang Y, 2005, Impaired long‐term potentiation and excitotoxic cell death in an animal model of tuberous sclerosis complex, Epilepsia, 46, 14

10.1016/j.tcb.2003.12.006

10.1007/s004010050691

Plank TL, 1999, The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in, Modern Pathology, 12, 539

Rayer PFO, 1835, Traité theorique et pratique des maladies de la peau

10.1177/088307389801301206

10.1177/08830738040190090301

Roske B, 2003, Tuberous sclerosis complex with disseminated telencephalic distribution of atypical cells and their relation to corticogenesis, Clinical Neuropathology, 22, 119

10.1016/j.mrrev.2006.03.001

10.1002/ajmg.10637

10.1177/08830738040190091401

Shepherd CW, 1991, Subependymal giant cell astrocytoma: a clinical, pathological, and flow cytometric study, Neurosurgery, 28, 864, 10.1227/00006123-199106000-00013

10.1007/BF01048239

10.1097/00019052-200004000-00001

10.1001/archneur.60.9.1286

10.1111/j.1535-7511.2005.00045.x

10.1016/j.conb.2004.04.001

10.1111/j.0013-9580.2004.23004.x

Talos DM, 2003, Dysplastic neurons in cortical tubers express selective alterations in AMPA and NMDA receptor subunits, Epilepsia, 44, 36

Talos DM, 2005, Altered glutamate receptor subunit expression in a mouse model of TSC, Epilepsia, 46, 125

10.1038/nn1566

10.1073/pnas.202476899

10.1016/0092-8674(93)90618-Z

10.1177/08830738040190090801

10.1038/sj.onc.1205435

10.1002/ana.10283

10.1126/science.277.5327.805

Van Slegtenhorst M, 1999, Mutational spectrum of the TSC1 gene in a cohort of 225 tuberous sclerosis complex patients: no evidence for genotype‐phenotype correlation, Journal of Medical Genetics, 36, 285, 10.1136/jmg.36.4.285

10.1002/ppul.10414

10.1111/j.1460-9568.2006.04594.x

Von Recklinghausen F, 1862, Eim Herz von einem Neugeborene welches mechrere theils nach aussen, theils nach den Höhlen prominirende Tumoren (Myomen) trug, Monatschr Geburtsheilkd, 20, 1

10.1111/j.1471-4159.2005.03538.x

Wang Y, 2005, Neocortical hyperexcitability in a mouse model of tuberous sclerosis complex, Epilepsia, 46, 13

10.1016/j.neulet.2006.03.011

10.1136/jmg.28.6.395

10.1177/08830738040190090901

10.1542/peds.2005-1206

10.1007/s00401-004-0865-8

10.1002/1531-8249(200101)49:1<67::AID-ANA10>3.0.CO;2-L

10.1177/08830738040190090701

10.1002/ana.10648

10.2174/1566524043359791

10.1016/S0074-7742(02)49019-8

10.1002/mc.2940140107

Yeung RS, 1997, Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis, The American Journal of Pathology, 151, 1477

10.1016/S1357-4310(98)01245-3

10.1177/08830738040190110101